Tiger Woods' Legal Team Challenges Subpoena for Prescription Drug Records
Golfing icon Tiger Woods is embroiled in a legal battle as his attorneys push back against a prosecutor's demand to access his prescription drug records. This request is part of an ongoing driving under the influence (DUI) case linked to a rollover crash that occurred on March 31. Woods has pleaded not guilty to the charges, but prosecutors have issued a subpoena seeking specific details about his prescriptions from January 1 to March 27.
Details of the Prosecution's Request
The prosecution is targeting information from a Palm Beach pharmacy, including the frequency of prescription fills, pill quantities, dosage amounts, and usage instructions. They argue that this data is crucial for understanding the circumstances surrounding the crash. However, Woods' legal representative, Douglas Duncan, has filed a motion challenging the relevance of this request. Duncan contends that the subpoena infringes upon his client's privacy rights and may not be directly pertinent to the case.
Legal Arguments and Protective Measures
In the motion, Duncan questions whether the state's demand for prescription records is necessary for the DUI proceedings. He emphasizes that such personal medical information should be protected from unnecessary disclosure. Should the court decide to grant access to the records, Duncan has requested a protective order. This order would ensure that the records are shared only with prosecutors, defence lawyers, and law enforcement officials, thereby preventing any public dissemination and safeguarding Woods' confidentiality.
Background of the Case
The case stems from a rollover car crash that led to Woods' arrest on DUI charges. Following the incident, reports indicated that Woods experienced hiccups and drowsiness in the back of a police car, adding complexity to the legal proceedings. The defence's challenge to the subpoena highlights broader issues about privacy in legal cases involving public figures. As the court reviews the motion, the outcome could set a precedent for how prescription drug records are handled in similar DUI investigations, balancing investigative needs with individual rights.
